R Squared LTD Pmv Pharmaceuticals, Inc. Transaction History
R Squared LTD
- $103 Billion
- Q4 2024
A detailed history of R Squared LTD transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, R Squared LTD holds 13,300 shares of PMVP stock, worth $17,556. This represents 0.02% of its overall portfolio holdings.
Number of Shares
13,300Holding current value
$17,556% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding PMVP
# of Institutions
84Shares Held
41.7MCall Options Held
3.1KPut Options Held
1.7K-
Orbimed Advisors LLC San Diego, CA6.48MShares$8.55 Million0.23% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.65MShares$4.81 Million0.08% of portfolio
-
Sio Capital Management, LLC New York, NY3.21MShares$4.24 Million2.53% of portfolio
-
Euclidean Capital LLC New York, NY2.63MShares$3.47 Million0.43% of portfolio
-
Alkeon Capital Management LLC New York, NY2.34MShares$3.09 Million0.01% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $60.2M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...